Caplight Directory>Companies>Brainstorm Diagnostics-preview>Brainstorm-diagnostics


Brainstorm Diagnostics

Brainstorm Diagnostics

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttp://www.brainstormdx.com/

Last Round

Seed

Dec 14, 2021

Company Overview

Brainstorm Diagnostics is a laboratory services company that is developing a blood test to diagnose damaged axons in concussion and traumatic brain injury.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

TBI blood testtraumatic brain injuryTBIconcussion diagnosisblood biomarkerimmunoassayTBI prognosisaxonal injurymedical diagnosticsSNTF proteinTBI dxprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Brainstorm Diagnostics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Brainstorm Diagnostics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedDec 14, 2021
View all Funding Rounds

Brainstorm Diagnostics Investors

Notable investors and investment history

InvestorRounds
Penn Center for InnovationSeed
View all Investors

Brainstorm Diagnostics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Brainstorm Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Brainstorm Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Year Founded2022
Last FundingDec 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.